Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT01449357
Eligibility Criteria:
Inclusion Criteria:
* Patients must have documented disease progression after TKI treatment (verified by CT scan and/or MRI according to RECIST).
Exclusion Criteria:
* Estimated life expectancy of less than 3 months.
* Received the following treatments within 2 weeks prior to Visit 2:
* Cytotoxic or cytostatic anti-cancer chemotherapy
* Total resection or irradiation of the target lesion
* Any investigational agent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01449357
Study Brief:
Protocol Section:
NCT01449357